Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA new Locations section appears with New South Wales and Victoria entries, and the old NSW/Victoria location blocks are removed.SummaryDifference0.3%
- Check53 days agoChange DetectedPublications section now notes that items are auto-filled from PubMed. It also updates the revision tag from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check60 days agoChange DetectedThe government funding status notice was removed from the page. The study details, contacts, and locations remain unchanged.SummaryDifference0.4%
- Check75 days agoChange DetectedNo substantive changes detected between the two screenshots. Core study details such as the title, NCT number, enrollment, and locations appear unchanged.SummaryDifference0.5%
- Check103 days agoChange DetectedMajor update: alerts about government funding status and a new version v3.2.0. Deletion of v3.1.0 indicates the version refresh.SummaryDifference3%
Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.